Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
112M
-
Number of holders
-
175
-
Total 13F shares, excl. options
-
83M
-
Shares change
-
+1.09M
-
Total reported value, excl. options
-
$1.75B
-
Value change
-
+$24.1M
-
Put/Call ratio
-
0.73
-
Number of buys
-
86
-
Number of sells
-
-74
-
Price
-
$21.12
Significant Holders of Evolent Health, Inc. - Class A Common Stock (EVH) as of Q2 2021
205 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock as of Q2 2021.
Evolent Health, Inc. - Class A Common Stock (EVH) has 175 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 83M shares
of 112M outstanding shares and own 74.39% of the company stock.
Largest 10 shareholders include Engaged Capital LLC (8.55M shares), VANGUARD GROUP INC (7.41M shares), JPMORGAN CHASE & CO (6.25M shares), BlackRock Inc. (5.78M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (4.77M shares), CREDIT SUISSE AG/ (3.99M shares), Bellevue Group AG (3.64M shares), DIMENSIONAL FUND ADVISORS LP (3.37M shares), BLAIR WILLIAM & CO/IL (2.52M shares), and EAGLE ASSET MANAGEMENT INC (2.5M shares).
This table shows the top 175 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.